Obesity Trial, Recruiting NCT06831045 Sponsor: University of Miami Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT06831045
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People with a body mass index (BMI) of 30 or higher (this is a standard weight-to-height measurement)
  • People scheduled to have their first total hip replacement surgery on one hip using a specific surgical approach called the Direct Anterior Approach (DAA)
  • People undergoing a first-time total hip replacement (not a revision or repeat surgery)

Who may not be able to join:

  • People with a BMI below 30
  • People who have previously had open surgery on the hip being treated
  • People who are unable or unwilling to have a type of anesthesia called spinal anesthesia combined with sedation monitoring
  • People who have allergies or medical reasons preventing them from receiving the standard medications used in the University of Miami's total hip replacement treatment protocol
  • People who are unable to give their own consent to participate
  • People under 18 years of age
  • People who are pregnant
  • People who are currently prisoners

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Victor H Hernandez, MD, University of Miami

Phone: 305-689-5195

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 March 2025
Est. completion
1 April 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Wound Healing measured in number of days; Patient satisfaction with scaring as measured by Patient Scar Assessment Scale; Scar cosmesis as measured by Observer Scar Assessment Scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov